Elizabeth Marie Robinson
Directeur/Membre du Conseil chez BREMBO N.V.
Profil
Elizabeth Marie Robinson founded Nicox SA in 1996, Indaco Venture Partners SGR SpA in 2018, where she is working as Vice Chairman from 2018, and Nicox Research Institute Srl in 1999, where she worked as President from 2006 to 2022.
Dr. Robinson also currently works at Brembo NV, as Independent Director, Intrepida Bio, Inc., as Director, Penta Foundation, as Director, and Italian Fulbright Commission, as Member.
Dr. Robinson also formerly worked at Lay Line Genomics SpA, as Chairman in 2008, Glomeria Therapeutics Srl, as Chairman, AGC Biologics SpA, as Independent Non-Executive Director, Recordati SpA, as Development Director in 1996, Directa Plus SpA, as Director, Directa Plus Plc, as Non-Executive Director, Biogenera SpA, as Director, Biouniversa Srl, as Director, Green Arrow Capital SGR SpA, as Investment Director from 2014 to 2018, Quadrivio SGR SpA, as Investment Director from 2014 to 2018, Techint Compagnia Tecnica Internazionale SpA, as Consultant-Technology Development from 1988 to 1990, Genzyme Srl, as Vice President in 1988, and Relivia SRL, as Founding Member.
Dr. Robinson received her graduate degree in 1979, doctorate degree in 1979, and doctorate degree in 1982 from Massachusetts Institute of Technology and undergraduate degree in 1977 from Wellesley College.
Postes actifs de Elizabeth Marie Robinson
Sociétés | Poste | Début |
---|---|---|
BREMBO N.V. | Directeur/Membre du Conseil | - |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Indaco Venture Partners SGR SpA
Indaco Venture Partners SGR SpA Investment ManagersFinance Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy. | Fondateur | 01/06/2018 |
Italian Fulbright Commission | Corporate Officer/Principal | - |
Anciens postes connus de Elizabeth Marie Robinson
Sociétés | Poste | Fin |
---|---|---|
Nicox Research Institute Srl
Nicox Research Institute Srl Miscellaneous Commercial ServicesCommercial Services Nicox Research Institute Srl operates as a research and nonclinical development center. The company was founded by Elisabeth Marie Robinson on September 21, 1999 and is headquartered in Bresso, Italy. | Fondateur | 01/11/2022 |
Green Arrow Capital SGR SpA
Green Arrow Capital SGR SpA Investment ManagersFinance Green Arrow Capital SGR SpA (Green Arrow Capital) is a private equity firm founded in 2000. The firm is headquartered in Rome, Italy. | Private Equity Investor | 01/06/2018 |
Quadrivio SGR SpA
Quadrivio SGR SpA Investment ManagersFinance Quadrivio SGR SpA (Quadrivio) is the Milan-based investment management subsidiary of GF SRL, itself a subsidiary of Quadrivio Group SpA in Italy. In 2001, the firm was established to manage the Quadrivio New Old Economy Fund, backed by banks, pension funds, institutions, insurance companies and private individuals. Quadrivio also manages the Quadrivio Q2 fund which eschews start-up initiatives and firms in turnaround situations. Quadrivio participates in the share capital of their investee companies, supporting their growth and development process by providing them with their international and management experience. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
DIRECTA PLUS PLC | Directeur/Membre du Conseil | 12/05/2017 |
Lay Line Genomics SpA
Lay Line Genomics SpA Pharmaceuticals: MajorHealth Technology Lay Line Genomics SpA engages in the provision of biotechnology solutions to medical challenges. It focuses on the discovery and development of new drugs and innovative therapies for Alzheimer''s and other neurological diseases. The company was founded in 2001 and is headquartered in Rome, Italy. | Président | 01/01/2008 |
Formation de Elizabeth Marie Robinson
Wellesley College | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
NICOX SA | Health Technology |
RECORDATI | Health Technology |
DIRECTA PLUS PLC | Producer Manufacturing |
BREMBO N.V. | Producer Manufacturing |
Entreprise privées | 15 |
---|---|
Genzyme Srl | |
Biogenera SpA
Biogenera SpA BiotechnologyHealth Technology Biogenera SpA researches and develops drugs for the treatment of pediatric cancer. It is a pharmaceutical company focused on development of drugs for treatment of cancer in paediatric patients. The firm develops new molecular therapies for childhood cancer. The company was founded by Roberto Tonelli and Andrea Pession in 2009 and is headquartered in Porretta Terme, Italy. | Health Technology |
Directa Plus SpA
Directa Plus SpA Miscellaneous Commercial ServicesCommercial Services Directa Plus SpA develops processes for the production of metals, nanoparticles, and graphene based materials. Its products include Graphene Plus (G+), elastomers and bicycle tyres to even lithium ion batteries, nano scale metal particles and nanoalloys for applications in the field of catalysts. The company was founded by Giulio Cesareo in 2005 and is headquartered in Lomazzo, Italy. | Commercial Services |
Relivia SRL
Relivia SRL Household/Personal CareConsumer Non-Durables Relivia SRL manufactures cosmetic products. The private company is based in Milan, Italy. | Consumer Non-Durables |
Lay Line Genomics SpA
Lay Line Genomics SpA Pharmaceuticals: MajorHealth Technology Lay Line Genomics SpA engages in the provision of biotechnology solutions to medical challenges. It focuses on the discovery and development of new drugs and innovative therapies for Alzheimer''s and other neurological diseases. The company was founded in 2001 and is headquartered in Rome, Italy. | Health Technology |
Techint Compagnia Tecnica Internazionale SpA
Techint Compagnia Tecnica Internazionale SpA Engineering & ConstructionIndustrial Services Techint Compagnia Tecnica Internazionale SpA provides engineering services. It offers engineering and project management, procurement and construction management, PMC and specialist consultancy. The company was founded in 1945 and is headquartered in Milan, Italy. | Industrial Services |
Nicox Research Institute Srl
Nicox Research Institute Srl Miscellaneous Commercial ServicesCommercial Services Nicox Research Institute Srl operates as a research and nonclinical development center. The company was founded by Elisabeth Marie Robinson on September 21, 1999 and is headquartered in Bresso, Italy. | Commercial Services |
Glomeria Therapeutics Srl
Glomeria Therapeutics Srl Miscellaneous Commercial ServicesCommercial Services Glomeria Therapeutics Srl is a holding company, which engages in the research, development, and marketing of medical devices for the treatment and cure of acute forms of nephropathy. Its products include DesmoPD, SmartPD, and Peritoneal Dialysis Solutions. The company was founded by Arduino Arduini on April 16, 2010 and is headquartered in Chieti, Italy. | Commercial Services |
Italian Fulbright Commission | |
Biouniversa Srl
Biouniversa Srl Medical SpecialtiesHealth Technology Biouniversa Srl discovers and develops diagnostic and therapeutic products based on the BAG3 protein. It offers diagnosis and prognosis of oncological diseases and cardiovascular therapies. The firm also focuses on achieving novel biomarkers for cardiovascular diseases and pancreatic cancer. The company was founded by Maria Caterina Turco and Arturo Leone in 2009 and it is headquartered in Montoro, Italy. | Health Technology |
AGC Biologics SpA
AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
Indaco Venture Partners SGR SpA
Indaco Venture Partners SGR SpA Investment ManagersFinance Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy. | Finance |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Health Technology |
Green Arrow Capital SGR SpA
Green Arrow Capital SGR SpA Investment ManagersFinance Green Arrow Capital SGR SpA (Green Arrow Capital) is a private equity firm founded in 2000. The firm is headquartered in Rome, Italy. | Finance |
Quadrivio SGR SpA
Quadrivio SGR SpA Investment ManagersFinance Quadrivio SGR SpA (Quadrivio) is the Milan-based investment management subsidiary of GF SRL, itself a subsidiary of Quadrivio Group SpA in Italy. In 2001, the firm was established to manage the Quadrivio New Old Economy Fund, backed by banks, pension funds, institutions, insurance companies and private individuals. Quadrivio also manages the Quadrivio Q2 fund which eschews start-up initiatives and firms in turnaround situations. Quadrivio participates in the share capital of their investee companies, supporting their growth and development process by providing them with their international and management experience. | Finance |